Sánchez-Fructuoso Ana I, Marques Maria, Prats Dolores, Conesa José, Calvo Natividad, Pérez-Contín M Jesús, Blazquez Jesús, Fernández Cristina, Corral Ervigio, Del Río Francisco, Núñez Jose R, Barrientos Alberto
Hospital Clínico San Carlos, Universidad Complutense, and Servicio de Atención Municipal de Urgencias de Madrid, Madrid, Spain.
Ann Intern Med. 2006 Aug 1;145(3):157-64. doi: 10.7326/0003-4819-145-3-200608010-00003.
The use of non-heart-beating donors could help shorten the list of patients who are waiting for a kidney transplant. Several reports describe acceptable results of transplantations from non-heart-beating donors who had in-hospital cardiac arrest, but few reports describe results of transplantations from non-heart-beating donors who had cardiac arrest that occurred outside of the hospital (Maastricht type I and type II donors).
To compare graft survival rates among patients receiving kidneys from heart-beating donors versus type I or type II non-heart-beating donors.
Retrospective cohort study of transplantations performed from January 1989 to December 2004.
Kidney transplant program of a teaching hospital in Madrid, Spain.
320 patients who received a kidney transplant from non-heart-beating donors (273 type I donors and 47 type II donors) and 584 patients who received a kidney transplant from heart-beating donors divided into 2 groups according to donor age (age <60 years [n = 458] and age > or =60 years [n = 126]).
The primary outcome measure was graft survival. The median follow-up time was 68 months (range, 9 to 198 months).
One- and 5-year graft survival rates were 90.7% and 85.5%, respectively, for transplants from heart-beating donors younger than 60 years of age; 79.8% and 73.3%, respectively, for transplants from heart-beating donors 60 years of age or older (P < 0.001); and 87.4% and 82.1%, respectively, for transplants from non-heart-beating donors (P = 0.22 [vs. those from heart-beating donors < 60 years of age] and P = 0.014 [vs. those from heart-beating donors >or = 60 years of age]). Graft survival did not differ between patients who received kidneys from heart-beating donors younger than 60 years of age and patients who received kidneys from non-heart-beating donors.
This single-site, observational study was retrospective, and immunosuppressive therapy regimens given to transplant recipients varied over time.
Outcomes of transplants from non-heart-beating donors and younger heart-beating donors are similar, and results for transplants from non-heart-beating donors improved compared with those from older heart-beating donors. On the basis of these results, the authors encourage other transplant units to adopt the use of type I and type II non-heart-beating donors.
使用非心脏跳动供体有助于缩短等待肾移植患者的名单。几份报告描述了来自医院内发生心脏骤停的非心脏跳动供体的移植可接受结果,但很少有报告描述来自医院外发生心脏骤停的非心脏跳动供体(马斯特里赫特I型和II型供体)的移植结果。
比较接受心脏跳动供体肾脏的患者与I型或II型非心脏跳动供体肾脏的患者的移植物存活率。
对1989年1月至2004年12月进行的移植进行回顾性队列研究。
西班牙马德里一家教学医院的肾移植项目。
320例接受非心脏跳动供体肾脏移植的患者(273例I型供体和47例II型供体)以及584例接受心脏跳动供体肾脏移植的患者,根据供体年龄分为2组(年龄<60岁[n = 458]和年龄≥60岁[n = 126])。
主要结局指标为移植物存活。中位随访时间为68个月(范围9至198个月)。
年龄小于60岁的心脏跳动供体移植的1年和5年移植物存活率分别为90.7%和85.5%;年龄60岁及以上的心脏跳动供体移植的分别为79.8%和73.3%(P < 0.001);非心脏跳动供体移植的分别为87.4%和82.1%(与年龄小于60岁的心脏跳动供体移植相比,P = 0.22;与年龄≥60岁的心脏跳动供体移植相比,P = 0.014)。接受年龄小于60岁的心脏跳动供体肾脏的患者与接受非心脏跳动供体肾脏的患者的移植物存活无差异。
这项单中心观察性研究是回顾性的,移植受者接受的免疫抑制治疗方案随时间变化。
非心脏跳动供体移植和较年轻心脏跳动供体移植的结果相似,与较老年心脏跳动供体移植相比,非心脏跳动供体移植的结果有所改善。基于这些结果,作者鼓励其他移植单位采用I型和II型非心脏跳动供体。